How fast will I lose weight on GLP-1s and is it sustainable?

Short answer

• Many people see most of their GLP‑1–related weight loss in the first 3–12 months. Typical clinical-trial averages are roughly 5–15% body weight in the first 6–12 months, with higher losses over 68–72 weeks for the more potent agents.
• However, weight loss varies a lot between individuals and usually requires continuing the medication (plus lifestyle change) to keep the weight off; stopping often leads to partial or full regain.

What the evidence and trials show (typical ranges)

• Semaglutide (Wegovy, the obesity dose 2.4 mg weekly): average losses in trials were around ~10–15% of body weight at ~68 weeks. Many patients lose most of that during the first 6–12 months.
• Tirzepatide (Mounjaro for diabetes; Zepbound for obesity): trial results show larger average losses than semaglutide, in many cases up to roughly ~15–20% (and in some trial arms even higher) at ~72 weeks.
• Liraglutide (Saxenda): smaller average losses than semaglutide/tirzepatide, often in the single-digit to low-double-digit percent range over months.

Key points about speed and variability

• Early phase: appetite suppression and reduced calorie intake usually cause relatively rapid initial loss (weeks to months).
• Slowing and plateau: weight loss typically slows after the first 3–6 months and may plateau.
• Individual factors: starting weight, dose, how strictly you follow diet/exercise/behavior changes, other medications, metabolic rate, and genetics all change the speed and amount of loss.

Sustainability — what to expect

• Continuing medication: in many studies, continuing the GLP‑1 maintains most of the lost weight. GLP‑1s act on appetite and satiety signals; if the drug is stopped, those signals often return and weight regain is common.
• Stopping the drug: trials that stopped the medication saw regained weight in many participants within months to a year unless intensive lifestyle interventions were added.
• Long-term plan: for sustainable results most people need a combination of medication (sometimes long-term), dietary/behavioral changes, physical activity, and ongoing medical follow-up.

Safety, monitoring and practical considerations

• Side effects: most common are nausea, vomiting, diarrhea, constipation; less commonly gallbladder issues, rare pancreatitis concerns. They can also affect blood sugar — doses often require diabetes-medication adjustments. Not for pregnancy.
• Monitoring: baseline and periodic follow-up with a clinician (weight, blood pressure, labs, GI tolerability, med interactions).
• Cost & access: brand-name obesity doses can be expensive and insurance coverage is variable. Off-label use (e.g., Ozempic or Mounjaro at diabetes doses) is a separate, clinician‑supervised decision.

Specific brands/services to consider (and why)

• Wegovy (semaglutide, obesity indication) — well-studied for weight loss with consistent trial results and an established dosing schedule for obesity.
• Zepbound (tirzepatide) or Mounjaro (tirzepatide for diabetes) — in trials produced larger average weight losses than semaglutide; option to discuss with clinician if appropriate.
• Saxenda (liraglutide) — option if other agents aren’t suitable or tolerated.
• Calibrate — a structured, medically supervised metabolic health program that integrates GLP‑1s with coaching and lifestyle work (good if you want a program rather than just a prescription).
• Telehealth clinics that offer supervised GLP‑1 programs (examples include Ro, Hims/Hers, One Medical) — convenient for appointments and often manage titration and follow-up; check credentials and reviews and prefer those with medical oversight and lab monitoring.

What I recommend you do next

1. Talk to your primary care doctor or an obesity-medicine specialist/endocrinologist to discuss which medication (if any) fits your medical history and goals.
2. Ask about realistic weight-loss expectations for your starting weight, side effects, monitoring plan, and costs/insurance coverage.
3. Plan for long-term strategies (behavioral changes, follow-up, and a plan for maintenance or what happens if you stop medication).

If you want, tell me your starting weight/height, any medical problems or medications, and whether you’re more interested in in-person specialty care or a telehealth program — I can give a more tailored estimate and suggest next steps.